Table 3 Quantification of UCH-L1 protein expression in tumors and their paired tissues on western blot.

From: Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors

proteins

UCHL-1

CDK4

CaSR

β-actin

*Ratio of UCH-L1/β-actin

IHC result

intensity

sample #

#4

1450

/

/

1224

1.18

+

# 289

492

/

/

459

1.07

+

#44

660

155

1645

835

0.79

+

#290

713

290

15

880

0.81

+

#67

171

656

0

1335

0.13

+

#5

434

754

0

1267

0.34

+

#5 N

32

12

0

777

0.04

Nor #1

0

206

0

631

0

Nor #2

0

116

0

458

0

Nor #3

0

0

0

365

0

  1. *The ratio of UCH-L1/β-actin in 6 tumor specimens (#4, #289, #44, #290, #67 and #5) was significantly higher than that in paired tissue (#5 N) or other normal pancreatic tissues (Nor 1, 2, 3), median 0.8 (0.13–1.18) vs. 0 (0–0.04), p = 0.0095, Mann-Whitney U test. The results from western blot are comparable with that from immunohistochemical (IHC) staining.